Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Extranodal NK-T-Cell

Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.

157 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Extranodal NK-T-Cell trial results

Completed

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

NCT01273090

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

NCT00898872

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Piedmont Hospital Atlanta, Georgia, United States
  • Northside Hospital Cancer Center Atlanta, Georgia, United States
  • Saint Joseph's Hospital of Atlanta Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

NCT00283985

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Département Maladies du Sang Angers, France
  • CH Annecy Annecy, France
  • Service de Radiothérapie, Polyclinique Bordeaux Nord Bordeaux, France
  • CHU Bordeaux Bordeaux, France
View all 25 locations
View Trial Details

Related conditions